American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. [electronic resource]
Producer: 20190923Description: 3360-3392 p. digitalISSN:- 2473-9537
- Administration, Oral
- Anticoagulants -- adverse effects
- Arginine -- analogs & derivatives
- Cardiovascular Surgical Procedures
- Chondroitin Sulfates -- therapeutic use
- Dermatan Sulfate -- therapeutic use
- Evidence-Based Medicine
- Fondaparinux -- therapeutic use
- Heparin -- adverse effects
- Heparitin Sulfate -- therapeutic use
- Hirudins
- Humans
- Peptide Fragments -- therapeutic use
- Pipecolic Acids -- therapeutic use
- Platelet Count
- Recombinant Proteins -- therapeutic use
- Renal Replacement Therapy
- Sulfonamides
- Thrombocytopenia -- chemically induced
- Venous Thromboembolism -- diagnosis
No physical items for this record
Publication Type: Journal Article; Practice Guideline
There are no comments on this title.
Log in to your account to post a comment.